SCHEMBL16629525

SCHEMBL16629525

Cn1nc(O)c(Br)c1C#N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15273742 0.77 SMN1; SMN2 (0.37)
SCHEMBL15273689 0.75 CSNK2A1 (0.32)
SCHEMBL16629293 0.72
SCHEMBL15273651 0.72
SCHEMBL16629292 0.72
SCHEMBL29255684 0.70
SCHEMBL15261543 0.69
SCHEMBL16629520 0.69 CSNK2A2 (0.31)
SCHEMBL24553235 0.67 KDM4E (0.47)
SCHEMBL15260721 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112812128-B Macrocyclic compounds as ALK and ROS modulators 正大天晴药业集团股份有限公司 2024-04-02 CN disclosed
CN-112812128-A Macrocyclic compounds as ALK and ROS modulators 正大天晴药业集团股份有限公司 2021-05-18 CN disclosed
WO-2015050989-A2 MACROCYCLIC COMPOUNDS FOR THE TREATMENT OF PROLIFERATIVE DISEASES CS THERAPEUTICS INC. (US) 2015-04-09 WO disclosed